Vm202

[dkcarl62]

I couldn't find any reference to this study on the forum.

https://clinicaltrials.gov/ct2/show/NCT02039401

Thoughts?

Deb

 

[lgelb]

It's DNA-based. ViroMed is testing its growth factor variants in a variety of cardiovascular and neurological indications, since the idea is cell regeneration. Nice results so far in diabetic peripheral neuropathy and they are in Phase III. Not as advanced a program yet in ALS; Reyon is the partner for that indication.

This trial is safety and tolerability, so more of an advancing science thing than likelihood of direct benefit. The problem may be that since we don't know why the motor neurons die to begin with, we don't know that any new ones will survive for any length of time using this approach. Hopefully, they would be healthier, as we hope with the stem cell approach.

Well worth monitoring.

 

[dkcarl62]

Thanks for your reply, Laurie!

Deb